☆ 4.3 Article

Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient

STEM CELL REVIEWS AND REPORTS (2021)

Related references

Note: Only part of the references are listed.

Letter Rheumatology

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Jerome Avouac et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Immunology

Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value

David Veyer et al.

Summary: This study analyzed 58 COVID-19 patients and found that 74.1% had SARS-CoV-2 RNAemia, which correlated with disease severity. Levels of SARS-CoV-2 RNAemia were associated with severity, suggesting that it could be a potential prognostic marker for COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia

Jonathan B. Parr

JAMA INTERNAL MEDICINE (2021)

Add to Collection

Article Cell & Tissue Engineering

Is COVID-19 a New Hematologic Disease?

Benjamin Debuc et al.

Summary: SARS-CoV-2 viruses are positive single-stranded RNA viruses that can lead to Covid-19, a respiratory infection with significant impact on the hematopoietic system and hemostasis, causing various cardiovascular complications. The medical community is exploring new treatment approaches for this infection, including targeted anti-inflammatory drugs and stem cell therapies, based on understanding Covid-19 pathophysiology, especially related to hematological disorders.

STEM CELL REVIEWS AND REPORTS (2021)

Add to Collection

Article Hematology

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

Thomas Hueso et al.

BLOOD (2020)

Add to Collection

Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient

Related references

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value

Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia

Is COVID-19 a New Hematologic Disease?

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

Export Citation

Share Paper